Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,854,835
+$341,125 QoQ
Shares Held
2,540
+41.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.6692913385826772.ToString("F0")%
Shared 0.ToString("F0")%
None 99.33070866141732.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $4,433,787 across 10 Biotechnology names. ARGX ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
2,540 | $1,854,835 | |
| 2 | CELC |
Celcuity Inc.
|
5,480 | $625,487 | |
| 3 | INCY |
Incyte Corp
|
5,394 | $507,683 | |
| 4 | SMMT |
Summit Therapeutics Inc.
|
25,640 | $486,134 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
900 | $401,886 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,066 | $201,527 | |
| 7 | EYPT |
EyePoint, Inc.
|
10,750 | $138,567 | |
| 8 | IMRX |
Immuneering Corp
|
21,120 | $111,302 |
All Filings in ARGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,854,835 | 2,540 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,513,710 | 1,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,281,879 | 1,738 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $600,829 | 1,090 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $336,179 | 568 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||